E6130, a Novel CX3CR1 Modulator, Attenuates Mucosal Inflammation and Reduces CX3CR1+ Leukocyte Trafficking in Two Murine Colitis Models
Molecular Pharmacology - United States
doi 10.1124/mol.117.108381
Full Text
Open PDFAbstract
Available in full text
Date
August 25, 2017
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)